shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > Lifestyle News > Health And Fitness News > Article > Focussing on bacteria alone will not help combat deadly antimicrobial resistance Lancet

Focussing on bacteria alone will not help combat deadly antimicrobial resistance: Lancet

Updated on: 13 September,2024 04:11 PM IST  |  New Delhi
IANS |

The study by The Lancet Journal, which comes ahead of the UN meeting on AMR later this month, calls for including resistance developed in many fungal pathogens to curb AMR

Focussing on bacteria alone will not help combat deadly antimicrobial resistance: Lancet

Image for representational purpose only. Photo Courtesy: istock

Listen to this article
Focussing on bacteria alone will not help combat deadly antimicrobial resistance: Lancet
x
00:00

Including fungal pathogens is crucial in the fight against deadly antimicrobial resistance, which is rapidly becoming a public health threat worldwide, according to a study published in The Lancet journal on Friday. 


The study, led by scientists at the universities of Manchester in the UK, Amsterdam, and the Westerdijk Institute in the Netherlands, showed that most fungal pathogens identified by the World Health Organisation (WHO) are either already resistant or rapidly acquiring resistance to antifungal drugs.



These fungal pathogens account for around 3.8 million deaths a year.


The study, which comes ahead of the UN meeting on AMR later this month, calls for including resistance developed in many fungal pathogens to curb AMR.

The scientists argued that focussing on bacteria alone will not help fully combat antimicrobial resistance (AMR). They called for immediate action, without which resistance to fungal disease will escalate.

Aspergillus, Candida, Nakaseomyces glabratus, and Trichophyton indotineae are the major fungicide resistant infections. These can have devastating health impacts on the elderly and people with weak immune systems.

Dr. Norman van Rhijn from The University of Manchester said that invasive fungal diseases have been responsible for many drug resistance problems over the past decades.

However, the threat of fungal pathogens and antifungal resistance has largely been “underrecognised” and “left out of the debate” by scientists, governments, clinicians, and pharmaceutical companies.

van Rhijn explained that “the close similarities between fungal and human cells make it hard to find treatments that selectively inhibit fungi with minimal toxicity to patients”.

The scientists suggested a global consensus on limiting the use of certain classes of antifungal molecules. They also stressed the need for collaborating on solutions and regulations that ensure food security and universal health for animals, plants, and humans.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK